Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Home
/
Tags
/
alpha-synuclein
alpha-synuclein
| 3 min read
by
Luisa Torres, PhD
An mRNA-degrading strategy attacks the root of Parkinson’s disease
Targeting α-synuclein mRNA before it had a chance to aggregate reduced its protein levels in cultured dopaminergic neurons and may protect neurons.
News
| 2 min read
by
Lauren Drake
T cell memory tips off early stages of Parkinson’s disease
T cells that react to a Parkinson’s disease-linked protein have an early, unique, and detectable gene signature.
News
| 2 min read
by
Tiffany Garbutt, PhD
Traveling to new frontiers: Antibody therapy for neurodegenerative diseases
Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.
Posters
Page 1 of 1 - 3 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Webinars
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Articles
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Compendium
Latest Issue
Volume 21 • Issue 1 • March 2025
March 2025
March 2025 Issue
Explore this issue